Wound Debridement Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 4.95 Billion |
| Market Size (2029) | USD 6.61 Billion |
| CAGR (2024 - 2029) | 5.97 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Wound Debridement Market Analysis
The Wound Debridement Market size is estimated at USD 4.95 billion in 2024, and is expected to reach USD 6.61 billion by 2029, growing at a CAGR of 5.97% during the forecast period (2024-2029).
This COVID-19 pandemic adversely affected the market worldwide due to the cancellation of many treatment procedures, including surgeries. For instance, according to the 2021 annual report published by Convatec, the advanced wound care segment, which included debridement products, declined revenue of 4.0% or 3.8% on a constant currency basis principally driven by the negative COVID-19 impact of reduced elective surgeries and restricted access to the healthcare setting. However, as per the same source mentioned above, the studied market is expected to witness substantial growth over the forecast period due to the return of elective operations in the post-pandemic period.
The major growth factor for the wound debridement market is the incidence of diabetes and associated wounds, as diabetic people are at higher risk of developing wounds requiring debridement. Thus, an increase in the diabetic population is expected to significantly impact the market. For instance, according to the report published by the Indiana University School of Medicine in November 2022, diabetes-related skin injuries, known as diabetic wounds, are particularly challenging to treat and frequently result in amputations or other consequences due to infections. Thus, wound debridement removes nonviable tissue, facilitates wound healing, and helps prevent these serious outcomes. So, the increasing prevalence of diabetes worldwide is expected to be a significant growth driver for the studied market.
Moreover, with the increase in the diabetic population, wound incidence is expected to increase, leading to an increase in the demand for wound debridement, which is expected to grow over the forecast period. For instance, according to the report published by the International Diabetes Federation (IDF) in November 2021, about 537 million adults in the age group 20-79 years are living with diabetes in 2021 globally, and this number is projected to increase to 643 million by 2030, and 783 million by 2045. Further, as per the same source, about 541 million adults were at risk of developing type-2 diabetes. This shows the increasing burden of diabetes, which increases the risk of wounds that may propel the market growth over the forecast period.
However, the high treatment cost associated with wound debridement of different types of wounds is expected to impede the study market over the forecast period.
Wound Debridement Market Trends
Gels in Product Segment is Expected to Have a Significant Share in the Market Over the Forecast Period
The gels segment is expected to have a significant share in the market as a product because it maintains a moist wound environment and has certain benefits as compared to other products, such as no inflammation, less bleeding, filling the dead space, and removal of necrotic tissues safely, without causing infection. In addition, gels are easily available and easy to use, which is why they are preferred by most of the population, especially the geriatric population, which is expected to boost the growth of the wound debridement market.
The increasing research funding for wound healing in developing countries like the United States and new product developments in the segment increase the widespread applications of products and the usage of these products, which is expected to boost market growth. For instance, as per the study report published by Wounds UK in March 2023, ChloraSolv Wound Debridement Gel showed much higher activity in more difficult in vitro biofilm testing as compared to other debridement methods/products, which increases the usage of this product due to higher activity of debridement and is expected to boost the market over the forecast period.
In addition, with the growing demand for effective wound debridement solutions, the companies are improving their offering with the launch of more advanced, and effective products. This is further expected to augment the segment growth. For instance, as per the NHS Trust in October 2022, the NHS Supply Chain launched an innovative gel that facilitated the removal of damaged tissue using chemical debridement as an alternative to sharp debridement. The product is cost-effective as compared to the standard care alone and provide additional benefits to the patient's quality of life, which is expected to have significant growth in the market over the forecast period.
Therefore, due to the abovementioned factors, the gels segment is expected to have a significant share in the wound debridement market during the forecast period.
North America is Expected to Occupy a Significant Share in the Market Over the Forecast Period
North American region is expected to hold a significant share in the wound debridement market owing to the increasing prevalence and incidence of diabetes and diabetic foot ulcers, a high number of surgeries owing to chronic diseases, and a growing aging population.
In the North American region, the United States is expected to have a major share in the wound debridement market due to factors such as the high incidence of wounds due to various reasons like infections, the growing geriatric population, and an increasing number of surgeries. For instance, as per the American Podiatric Medical Association factsheet released in September 2021, 75% of Americans at some point in their lives encounter foot health issues of varied severity, with an annual average of 1.4-foot issues affecting about 19% of United States citizens. It also reported that about 5% of the United States population has foot infections such as athlete's foot, other fungal infections, and warts each year. Hence, there is an increasing need for debridement for the high burden of foot infections, which is expected to boost the market growth in the region.
Furthermore, the increasing strategies of market players like acquisitions and product agreements increase the widespread distribution of wound debridement services and likely propel the market growth. For instance, in December 2021, Essity Aktiebolag acquired a company based in the United States called Hydrofera, which offers technology and products within advanced wound care, including debridement products.
Similarly, in November 2022, Sanara MedTech Inc. and InfuSystem Holdings, Inc. established a partnership, SI Wound Care, LLC, which focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction. The partnership is expected to enable InfuSystem to offer new customers to Sanara's advanced wound care product line, including necrotic tissue debridement and associated services.
Therefore, owing to the abovementioned factors, the North American region is expected to occupy a significant market share during the study's forecast period.
Wound Debridement Industry Overview
The wound debridement market is competitive, with many global players operating and offering innovative products in the studied market. The market is expected to become more competitive with the business expansion strategies employed by the companies to gain more market share, such as product launches, mergers and acquisitions, collaborations, and other activities. Some of the key players in the market are B. Braun SE, Smith+Nephew, Lohmann & Rauscher, Histologics, LLC, and Medaxis, among others.
Wound Debridement Market Leaders
-
Lohmann & Rauscher
-
Histologics, LLC
-
B. Braun SE
-
Smith+Nephew
-
Medaxis
*Disclaimer: Major Players sorted in no particular order
Wound Debridement Market News
- March 2023: SolasCure announced the final closing of a GBP 10.9 million (USD 13.3 million) Series B fund to advance wound care innovation. The funding will support the development of Aurase Wound Gel and progress toward further Phase II clinical trials of innovative wound debriding enzymes.
- February 2023: SERDA Therapeutics submitted an Investigational New Drug Application (IND) to the United States FDA for its lead product SN514 hydrogel, an enzymatic wound debriding agent.
Wound Debridement Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidence of Diabetes and Associated Wounds
- 4.2.2 Increase in Volume of Surgical Procedures
- 4.2.3 Growing Geriatric Population
-
4.3 Market Restraints
- 4.3.1 High Treatment Cost
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD)
-
5.1 By Product
- 5.1.1 Gels
- 5.1.2 Ointments & Creams
- 5.1.3 Surgical Devices
- 5.1.4 Ultrasound Devices
- 5.1.5 Mechanical Debridement Pads
- 5.1.6 Other Wound Debridement Products
-
5.2 By Method
- 5.2.1 Surgical Method
- 5.2.2 Enzymatic Method
- 5.2.3 Mechanical Method
- 5.2.4 Autolytic Method
- 5.2.5 Other Methods
-
5.3 By Wound Type
- 5.3.1 Chronic Ulcers
- 5.3.2 Surgical & Traumatic Wounds
- 5.3.3 Burns
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Arobella Medical
- 6.1.2 B. Braun SE
- 6.1.3 DeRoyal Industries, Inc.
- 6.1.4 Histologics, LLC
- 6.1.5 Lohmann & Rauscher
- 6.1.6 Medaxis
- 6.1.7 Bioventus (Misonix, Inc.)
- 6.1.8 PulseCare Medical
- 6.1.9 Smith + Nephew
- 6.1.10 Convatec Group PLC
- 6.1.11 PAUL HARTMANN AG
- 6.1.12 RLS Global
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityWound Debridement Industry Segmentation
As per the report's scope, wound debridement is a procedure to remove contaminated, dead tissue and foreign substances from a wound to reduce various types of microbes, toxins, and other foreign materials that inhibit wound healing. The Wound Debridement Market is Segmented by Product (Gels, Ointments and Creams, Surgical Devices, Ultrasound Devices, Mechanical Debridement Pads, and Other Wound Debridement Products), Method (Surgical Method, Enzymatic Method, Mechanical Method, Autolytic Method, and Others), Wound Type (Chronic Ulcers, Surgical & Traumatic Wounds, and Burns), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across the major regions globally. The report offers the value (USD) for all the above segments.
| By Product | Gels | |
| Ointments & Creams | ||
| Surgical Devices | ||
| Ultrasound Devices | ||
| Mechanical Debridement Pads | ||
| Other Wound Debridement Products | ||
| By Method | Surgical Method | |
| Enzymatic Method | ||
| Mechanical Method | ||
| Autolytic Method | ||
| Other Methods | ||
| By Wound Type | Chronic Ulcers | |
| Surgical & Traumatic Wounds | ||
| Burns | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Wound Debridement Market Research FAQs
How big is the Wound Debridement Market?
The Wound Debridement Market size is expected to reach USD 4.95 billion in 2024 and grow at a CAGR of 5.97% to reach USD 6.61 billion by 2029.
What is the current Wound Debridement Market size?
In 2024, the Wound Debridement Market size is expected to reach USD 4.95 billion.
Who are the key players in Wound Debridement Market?
Lohmann & Rauscher, Histologics, LLC, B. Braun SE, Smith+Nephew and Medaxis are the major companies operating in the Wound Debridement Market.
Which is the fastest growing region in Wound Debridement Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Wound Debridement Market?
In 2024, the North America accounts for the largest market share in Wound Debridement Market.
What years does this Wound Debridement Market cover, and what was the market size in 2023?
In 2023, the Wound Debridement Market size was estimated at USD 4.67 billion. The report covers the Wound Debridement Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Wound Debridement Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Wound Debridement Industry Report
Statistics for the 2024 Wound Debridement market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Wound Debridement analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
